The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 7 rounds in the feed, most often at Series B and in AI.
Pavilion Capital Partners is a growth-stage venture investor.
Venture capitalNew York City, USApavilioncapital.comRounds from 2019-09-10 to 2025-11-20
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Genspark Genspark sells an all-in-one AI workspace that offers various tools and applications for content creation, productivity, and design. | Series B Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $275M | 2025-11-20 | [ PART ] |
Strategic investment Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. |
| $13M |
| 2025-07-31 |
| [ PART ] |
Flare Therapeutics A biotech startup targeting transcription factors | Series B Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $123M | 2023-03-22 | [ PART ] |
Insilico Medicine AI-powered drug discovery and development tools to pharmaceutical companies and researchers. | Series D Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $60M | 2022-06-06 | [ PART ] |
Insilico Medicine AI-powered drug discovery and development tools to pharmaceutical companies and researchers. | Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $255M | 2021-06-22 | [ PART ] |
Inari Innovative agricultural solutions leveraging AI and gene editing technology for plant breeding. | Series D Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $208M | 2021-05-12 | [ PART ] |
Insilico Medicine AI-powered drug discovery and development tools to pharmaceutical companies and researchers. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $37M | 2019-09-10 | [ PART ] |